Any feedback?
Please rate this page
(search_result.php)
(0/150)

BRENDA support

Refine search

Search Crystallization (Commentary)

show results
Don't show organism specific information (fast!)
Search organism in taxonomic tree (slow, choose "exact" as search mode, e.g. "mammalia" for rat,human,monkey,...)
(Not possible to combine with the first option)
Refine your search

Search term:

Results 1 - 10 of 19 > >>
EC Number Crystallization (Commentary)
Show all pathways known for 2.5.1.31Display the word mapDisplay the reaction diagram Show all sequences 2.5.1.31-
Show all pathways known for 2.5.1.31Display the word mapDisplay the reaction diagram Show all sequences 2.5.1.31apoenzyme and enzyme bound to dimethylallyl diphosphate, geranyl diphosphate and dimethylallyl diphosphate plus S-thiologeranyl diphosphate
Show all pathways known for 2.5.1.31Display the word mapDisplay the reaction diagram Show all sequences 2.5.1.31C234A UPPS mutant to prevent intra-molecular disulfide bond formed during the long period of crystallization process is crystallized using the hanging drop method. The protein is a dimer and each subunit contains a catalytic domain and a pairing domain. Two subunits are tightly associated through the central beta-sheet and a pair of long alpha-helices. Helicobacter pylori UPPS has a 1.5-turn shorter alpha5 helix in the dimer interface. This may weaken the dimer formation for Helicobacter pylori UPPS. The catalytic domain is composed of six beta-strands and four beta-helices and the central tunnel-shaped active site is surrounded by 2 alpha-helices and 4 beta-strands
Show all pathways known for 2.5.1.31Display the word mapDisplay the reaction diagram Show all sequences 2.5.1.31co-crystal structure of UPPS in complex with (2E,6E)-farnesyl diphosphate
Show all pathways known for 2.5.1.31Display the word mapDisplay the reaction diagram Show all sequences 2.5.1.31crystal structure of Helicobacter pylori UPPS and mutant by hanging drop method
Show all pathways known for 2.5.1.31Display the word mapDisplay the reaction diagram Show all sequences 2.5.1.31hanging drop set-up
Show all pathways known for 2.5.1.31Display the word mapDisplay the reaction diagram Show all sequences 2.5.1.31hanging-drop method
Show all pathways known for 2.5.1.31Display the word mapDisplay the reaction diagram Show all sequences 2.5.1.31in complex with farnesyl diphosphate. Virtual screening of inhibitors from a library of 58,635 compounds, modelling of inhibitors N,N'-bis(6-chloro-1,3-benzothiazol-2-yl)methanedisulfonamide and 3-[5-(5,6-dihydrobenzimidazo[1,2-c]quinazolin-6-yl)-2,5-dihydrofuran-2-yl]benzenesulfonamide into structure
Show all pathways known for 2.5.1.31Display the word mapDisplay the reaction diagram Show all sequences 2.5.1.31purified His-tagged wild-type enzyme in complex with Mg2+, sulfates, and 2 molecules of Triton X-100, hanging drop vapour diffusion method, 0.002 ml protein solution containing 10 mg/ml protein, 2% Triton X-100, 5 mM MgCl2, and 0.66 mM farnesyl diphosphate, is mixed with equal volume of mother liquid containing 0.01 M CoCl2, 0.1 M MES, pH 6.5, and 1.8 M ammonium sulfate, equilibration against 0.2 ml mother liquid at 25°C, 10 days, X-ray diffraction structure determination and analysis at 1.73 A resolution, modeling
Show all pathways known for 2.5.1.31Display the word mapDisplay the reaction diagram Show all sequences 2.5.1.31purified His-tagged wild-type enzyme, hanging drop vapour diffusion method, high concentration of sulfate or phosphate in the mother liquid to prevent binding of Triton X-100 or substrates during crystallization, 0.002 ml mother liquid containing 25% ethylene glycol, pH 7.5, mixed with 0.002 ml protein solution containing 10 mg/ml protein, 1 mM peptide, 0.05% Triton X-100, and 0.5 mM MgCl2, equilibration against 0.2 ml mother liquid at 25°C, 5 days, crystals are then soaked in mother liquid containing 0.23 mM farnesyl diphosphate, X-ray diffraction structure determination and analysis at 2.4 A resolution, modeling
Results 1 - 10 of 19 > >>